FindTrial
Sign In

Based on the clinical characteristics of lung interstitial abnormalities in patients with pulmonary nodule resection

Based on the clinical characteristics of lung interstitial abnormalities in patients with pulmonary nodule resection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099428
Enrollment
Unknown
Registered
2025-03-24
Start date
2024-01-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial lung abnormality

Interventions

Non-subpleural ILA group:None
Subpleural nonfibrotic ILA group:None
Subpleural fibrotic ILA group:None

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pulmonary nodule resection was performed in our hospital; 2. Chest HRCT was performed in our hospital within one month before surgery, and the performance met the diagnostic criteria for ILA; 3. All patients were followed up for at least 2 years by chest HRCT in our hospital.

Exclusion criteria

Exclusion criteria: 1. Previous diagnosis or suspicion of interstitial lung disease; 2. Current or previous history of other malignant tumors.

Design outcomes

Primary

MeasureTime frame
ILA Progression outcome;Death outcome;—

Countries

China

Contacts

Public ContactRuolin Mao

Shanghai Chest Hospital

maoruolin68@163.com+86 188 1787 5725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026